Design of potent GlyT1 inhibitors: in vitro and in vivo profiles
{{output}}
Inhibitors of Gly transporter type-1 (GlyT1) for the treatment of schizophrenia have been pursued on the basis of the NMDA receptor (R) hypofunction hypothesis, which stems largely from the observation that NMDAR antagonists induce symptoms that more closely m... ...
